KISSEI PHARMACEUTICAL CO.,LTD.【JP:4547】Cash flow
Market cap
¥229B
P/E ratio
15.6x
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | 2,203 | 2,343 | 2,370 | 2,492 | 2,607 | 2,562 | 3,148 | 3,730 | 4,109 | 4,254 | 4,615 |
| Cash from operations | 6,667 | 5,763 | 6,441 | 8,845 | 6,346 | 13,934 | -2,542 | 1,533 | -6,679 | -1,677 | 6,521 |
| Capital expenditures | -1,974 | -1,978 | -1,201 | -1,867 | -1,093 | -879 | -931 | -1,489 | -2,103 | -1,201 | -4,507 |
| Cash from investing | -3,168 | -5,685 | -4,671 | -2,959 | -2,087 | 490 | -9,329 | 10,776 | 6,001 | 8,690 | 4,952 |
| Payments for dividends | -2,110 | -2,103 | -2,201 | -2,270 | -2,289 | -2,382 | -2,475 | -2,536 | -3,135 | -3,722 | -3,801 |
| Repurchases of common stock | -7,906 | -2 | -1,649 | -4,464 | - | - | -1,303 | - | - | -6,000 | -5,293 |
| Proceeds from issuance of term debt, net | 200 | 110 | 238 | 248 | 91 | - | - | - | - | - | - |
| Repayments of term debt | -171 | -85 | -85 | -70 | -30 | -1,934 | -16 | -13 | - | - | - |
| Cash from financing | -10,081 | -2,146 | -3,766 | -6,621 | -2,306 | -4,419 | -4,000 | -2,756 | -3,420 | -10,006 | -9,325 |